Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01470274

Enrollment

Registered

2011-11-11

Start date

2011-11-30

Completion date

2012-02-29

Last updated

2016-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Chronic Obstructive Pulmonary Disease

Keywords

Blood volume, CO-rebreathing, COPD, CVD

Brief summary

The primary objective is to establish the safety of the CO-rebreathing method for measuring total blood and plasma volume in CAD patients. The working hypothesis is that the CO-rebreathing method is safe in use with coronary artery disease patients and that it does not cause myocardial ischemia or cardiovascular damage.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Stable coronary artery disease * Stable COPD * Optimal medication

Exclusion criteria

* Unstable disease * co-morbidities

Countries

Norway

Outcome results